86.22.Z - Specialist medical practice activities
72.19 - Other research and experimental development on natural sciences and engineering
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,5 | 0,6 | 24,1 |
Gross profit (loss) | 0,5 | 0,5 | 0,6 | 21,2 |
EBITDA | 0,6 | 0,7 | 0,8 | 16,1 |
Short time liabilities | 0 | 0 | 0,1 | 380,3 |
Other operating costs | 0 | 0 | 0 | 135,7 |
Equity capital | 0,8 | 0,5 | 0,7 | 32 |
Operating profit (EBIT) | 0,5 | 0,5 | 0,6 | 22,4 |
Assets | 0,8 | 0,5 | 0,7 | 40,1 |
Net profit (loss) | 0,4 | 0,5 | 0,6 | 21,2 |
Cash | 0,8 | 0,5 | 0,7 | 41,1 |
Net income from sale | 4,3 | 4,5 | 4,7 | 2,6 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | -100 |
Working assets | 0,8 | 0,5 | 0,7 | 40,1 |
Other income costs | 0 | 0 | 0 | -95,7 |
Depreciation | 0,1 | 0,1 | 0,1 | -7,3 |
% | % | % | p.p. | |
Profitability of capital | 54,4 | 93,9 | 86,2 | -7,7 |
Equity capital to total assets | 98,7 | 97,7 | 92 | -5,7 |
Gross profit margin | 10,8 | 11,7 | 13,8 | 2,1 |
EBITDA Margin | 13,6 | 14,7 | 16,6 | 1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 1 | 1 | 5 | 4 |
Current financial liquidity indicator | 76.45775604248047 | 43.08623504638672 | 12.56531810760498 | -30,5 |
Net dept to EBITDA | -1.3224787712097168 | -0.7506478428840637 | -0.9116689562797546 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane